Pure Global AI
NCT06108193Recruiting

Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris

A Phase I/II Clinical Study of Topical Minoxidil in Acne Vulgaris
Chang Gung Memorial HospitalPhase 1/2ClinicalTrials.govdrug
Study focus
Disease/Condition
Acne Vulgaris
Drug/Device/Intervention
topical minoxidil in Acne Vulgaris
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Chang Gung Memorial Hospital
Location
Taoyuan, Taiwan
Timeline & enrollment
Phase
Phase 1/2
Start date
Jul 11, 2023
End date
Dec 31, 2023
Enrollment
26 participants
Primary outcome

Change from baseline systolic blood pressure

Summary

Patients with acne vulgaris (AV) appeared to be a chronic inflammation with a wide range in
 teenagers and adult. The protocol design is as follows.
 
 The subjects enrolled through inclusion and exclusion criteria will undergo the blood and
 urine biochemical tests for baseline record. The photos from the subjects will be recorded
 per day, and the blood and urine biochemical tests will be recorded per week.
 
 Objectives: primary: to test the toxicity of topical minoxidil in treatment of acne vulgaris;
 second: to evaluate the response and disease control rate in this pilot study.
 
 Measurement: Time to resolution of individual acne lesions (14 days) Monitor of treatment
 efficacy: number of inflammatory acne lesions counting, time to resolution of individual acne
 lesion, and degree of acne severity measurement.

ICD-10 classifications
Acne vulgarisAcneAcne, unspecifiedAcné excoriéeOther acne
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06108193
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06108193 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Chang Gung Memorial Hospital and is currently Recruiting. The study focuses on Acne Vulgaris. Target enrollment is 26 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.